SAN RAFAEL, Calif.,
Aug. 28, 2019 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced
that Dan Spiegelman, Executive Vice
President and Chief Financial Officer, will present at the Morgan
Stanley 17th Annual Global Healthcare Conference on September 10, 2019 at 8:35am ET in New York. To access the live
webcast, please visit the investor section of the BioMarin website,
www.biomarin.com. A replay will also be archived on the site for at
least one week following each event.
About BioMarin
BioMarin is a global biotechnology
company that develops and commercializes innovative therapies for
people with serious and life-threatening rare disorders. The
company's portfolio consists of seven commercialized products and
multiple clinical and pre-clinical product
candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
|
Contacts:
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Debra
Charlesworth
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-morgan-stanley-17th-annual-global-healthcare-conference-on-september-10-2019-in-new-york-300908170.html
SOURCE BioMarin Pharmaceutical Inc.